CIMI – CIMI Consulting And Services

Strategic Clinical Development & Medical Affairs Consulting

CIMI partners with diagnostics, medical device, and life sciences organizations to develop clinically meaningful evidence strategies that support regulatory, medical, and commercial advancement.

Clinical Strategy & Evidence Planning

CIMI provides strategic clinical leadership to help life sciences companies align evidence-generation strategies with regulatory objectives, product positioning, and long-term development goals.

Clinical development strategy alignment
Submission-focused study planning
Endpoint and clinical evidence strategy guidance
Cross-functional clinical leadership support
Clinical risk and feasibility assessment

Strong clinical strategy early in development helps reduce risk and support more effective product advancement decisions.

Medical Affairs & Scientific Engagement

CIMI supports medical and scientific strategy by helping organizations translate clinical evidence into credible scientific communication and stakeholder alignment.

KOL and scientific engagement strategy
Clinical evidence positioning guidance
Medical communication strategy support
Scientific narrative and communication alignment
Stakeholder and investigator engagement guidance

Effective scientific communication helps clinical evidence resonate with physicians, investigators, stakeholders, and future partners.

Strategic clinical and medical leadership. When you need it most.

Let’s discuss how we can support your next phase of development.

Who We Are

CIMI is a clinical strategy and medical affairs consultancy supporting medical device, diagnostics, and biotech organizations navigating complex development decisions. We provide senior level leadership in clinical design, program strategy, and evidence planning.

Our work includes study architecture, submission aligned endpoint strategy, executive program guidance, and sponsor side oversight. We partner with internal teams and external CROs to ensure alignment, inspection readiness, and defensible evidence generation while maintaining appropriate sponsor and CRO responsibilities.

From early feasibility through post market evidence development, CIMI brings disciplined thinking and experienced leadership to clinical programs when clarity and structure matter most.